Blake Coblentz will present at Life Sciences Masters 2023. Blake will examine current trends in ANDA litigation and best practices for dealing with those trends and issues. Among the specific items to be discussed, he will address Jazz Pharmaceuticals’ patents covering a method of distributing Xyrem being de-listed from the Orange Book because the patent’s claims are directed to a method of distributing a drug and not a method of using or administering a drug; and How a patent owner and generic can settle an ANDA case without being charged with an anti-trust violation.